Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Timothy Westlake"'
Autor:
Jing Cui, Jingcheng Zhou, Weiqing He, Juan Ye, Timothy Westlake, Rogelio Medina, Herui Wang, Bhushan L. Thakur, Juanjuan Liu, Mingyu Xia, Zhonggui He, Fred E. Indig, Aiguo Li, Yan Li, Robert J. Weil, Mirit I. Aladjem, Laiping Zhong, Mark R. Gilbert, Zhengping Zhuang
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 41, Iss 1, Pp 1-15 (2022)
Abstract Background Compared to normal cells, cancer cells exhibit a higher level of oxidative stress, which primes key cellular and metabolic pathways and thereby increases their resilience under oxidative stress. This higher level of oxidative stre
Externí odkaz:
https://doaj.org/article/445271d602864e3ab3bd004faac35132
Autor:
Arbor G. Dykema, Boyang Zhang, Bezawit A. Woldemeskel, Caroline C. Garliss, Rufiaat Rashid, Timothy Westlake, Li Zhang, Jiajia Zhang, Laurene S. Cheung, Justina X. Caushi, Drew M. Pardoll, Andrea L. Cox, Hongkai Ji, Kellie N. Smith, Joel N. Blankson
Publikováno v:
EBioMedicine, Vol 80, Iss , Pp 104048- (2022)
Summary: Background: COVID-19 mRNA vaccines elicit strong T and B cell responses to the SARS-CoV-2 spike glycoprotein in both SARS-CoV-2 naïve and experienced patients. However, it is unknown whether the post-vaccine CD4+ T cell responses seen in pa
Externí odkaz:
https://doaj.org/article/a44b594af9e6401aae4458d7a54a5518
Autor:
Dieila Giomo De Lima, Mariana Brait, Laura Palmieri, Fernando T. Zamuner, Esther Broner, Kellie N. Smith, Timothy Westlake, Or Malca, Sol Efroni, Ido Sloma, David Sidransky
Publikováno v:
Cancer Research. 83:2121-2121
Head and neck squamous cell carcinoma (HNSCC) is a global health problem. Successful immunotherapy in HNSCC is currently based on the ability to block the interaction of PD1 and PDL1 and abolish the inhibition of CD8+ T cells, thus enhancing the anti
Autor:
Jing Cui, Jingcheng Zhou, Weiqing He, Juan Ye, Timothy Westlake, Rogelio Medina, Herui Wang, Bhushan L. Thakur, Juanjuan Liu, Mingyu Xia, Zhonggui He, Fred E. Indig, Aiguo Li, Yan Li, Robert J. Weil, Mirit I. Aladjem, Laiping Zhong, Mark R. Gilbert, Zhengping Zhuang
Publikováno v:
Journal of experimentalclinical cancer research : CR. 41(1)
Background Compared to normal cells, cancer cells exhibit a higher level of oxidative stress, which primes key cellular and metabolic pathways and thereby increases their resilience under oxidative stress. This higher level of oxidative stress also c
Autor:
Arbor G. Dykema, Boyang Zhang, Bezawit A. Woldemeskel, Caroline C. Garliss, Rufiaat Rashid, Timothy Westlake, Li Zhang, Jiajia Zhang, Laurene S. Cheung, Justina X. Caushi, Drew M. Pardoll, Andrea L. Cox, Hongkai Ji, Kellie N. Smith, Joel N. Blankson
Publikováno v:
EBioMedicine. 80
COVID-19 mRNA vaccines elicit strong T and B cell responses to the SARS-CoV-2 spike glycoprotein in both SARS-CoV-2 naïve and experienced patients. However, it is unknown whether the post-vaccine CD4+ T cell responses seen in patients with a history
Autor:
Damien D’Amours, Guðjón Ólafsson, Prashant K. Mishra, Peter H. Thorpe, Ziad M. Jowhar, Munira A. Basrai, Richard Baker, Lars Boeckmann, Timothy Westlake, Lauren E. Dittman
Publikováno v:
Molecular Biology of the Cell
Evolutionarily conserved polo-like kinase, Cdc5 (Plk1 in humans), associates with kinetochores during mitosis; however, the role of cell cycle–dependent centromeric ( CEN) association of Cdc5 and its substrates that exclusively localize to the kine
Publikováno v:
Heat Shock Proteins ISBN: 9783030231576
Heat shock protein 90 (HSP-90) has been identified in many disease processes including cancer, neurodegeneration, autoimmune diseases, and cancers. Great effort has been expended in the development of specific inhibitors of the N-terminal and C-termi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e641f89dad916c0a75bdec51524d5e96
https://doi.org/10.1007/978-3-030-23158-3_10
https://doi.org/10.1007/978-3-030-23158-3_10
Autor:
Yu Yao, Zhengping Zhuang, Jared S. Rosenblum, Qi Song, Xiaoyu Cao, Kaiyong Yang, Timothy Westlake, Herui Wang, Jing Cui, Qi Zhang, Mark R. Gilbert
Publikováno v:
Neuro-Oncology. 20:vi129-vi129
BACKGROUND: The need for novel therapies for GBM treatment is well established. While chimeric antigen receptor (CAR)-engineered T cells represent a promising cancer treatment modality, highly expressed unique cell surface antigens are essential. We